(Q45953735)
Statements
1 reference
Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy. (English)
1 reference
Yosuke Horita
1 reference
Y Yamada
1 reference
Y Hirashima
1 reference
K Kato
1 reference
T Nakajima
1 reference
T Hamaguchi
1 reference
Y Shimada
1 reference
25 June 2009
1 reference
65
1 reference
3
1 reference
467-471
1 reference